Malaria Vaccines

Research for development of a malaria vaccine is currently underway to find an effective modality to control and eliminate the transmission of malaria. To date, no vaccine has been found to be efficacious in fighting against malaria. Here is the latest research on malaria vaccines.

January 19, 2022

Malaria abrogates O'nyong-nyong virus pathologies by restricting virus infection in nonimmune cells.

Life Science Alliance
Anthony Torres-RuestaLisa Fp Ng
January 19, 2022
Comment / Editorial

Antimalarial Hemozoin Inhibitors (β-Hematin Formation Inhibition): Latest Updates.

Combinatorial Chemistry & High Throughput Screening
Jorddy N Cruz, Suraj N Mali
January 18, 2022
Preprint
Open Access

Metabolic competition between lipid metabolism and histone methylation regulates sexual differentiation in human malaria parasites.

BioRxiv : the Preprint Server for Biology
C. T. HarrisBjorn F. C. Kafsack
January 17, 2022

Anti-plasmodial, Cytotoxic and Antioxidant Activities of Selected Ghanaian Medicinal Plants.

Journal of Evidence-based Integrative Medicine
Regina Appiah-OpongAlexander K Nyarko
January 17, 2022

Healthcare Professional Preferences for Prescribing Artemisinins and Quinine for Malaria in Burundi.

The East African Health Research Journal
Aîné-Ernest NiyonkuruMike Davis
January 17, 2022
Open Access

A critical review on modulators of Multidrug Resistance Protein 1 in cancer cells.

PeerJ
Vivian Osei Poku, Surtaj Hussain Iram
January 17, 2022
Review
Open Access

Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?

Frontiers in Pharmacology
Zhaowu MaBoon-Cher Goh
January 17, 2022

The cognitive burden of severe malaria in the Ugandan classroom and the effects of a computerized intervention.

Applied Nursing Research : ANR
Katherine MillerBruno Giordani
January 16, 2022
Open Access

Preimmunization correlates of protection shared across malaria vaccine trials in adults.

NPJ Vaccines
Maxwell L NealKenneth D Stuart
January 16, 2022
Review

Emerging role of γδ T cells in protozoan infection and their potential clinical application.

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
Awnish KumarRajiv Kumar
January 15, 2022
Open Access

Elucidating functional epitopes within the N-terminal region of malaria transmission blocking vaccine antigen Pfs230.

NPJ Vaccines
Kazutoyo MiuraTakafumi Tsuboi
January 15, 2022
Review
Open Access

The Potential Mechanisms by which Artemisinin and Its Derivatives Induce Ferroptosis in the Treatment of Cancer.

Oxidative Medicine and Cellular Longevity
Yingying HuXiang Li

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Amoebiasis

Amoebiasis, infection by the protozoan parasite Entamoeba histolytica, remains a global health problem, despite the availability of effective treatment. Here is the latest research.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

© 2022 Meta ULC. All rights reserved
/feed-previews/malaria-vaccines/44aa4521-a27f-417a-8746-5185b6dc399b